-
Most Popular

Biotech Stocks
Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

3 Promising Biotech Stocks for the Long-Term: August 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.

The 3 Best Healthcare Stocks to Buy in August 2024
These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.
Recent Biotech Stocks Articles
Why Is Novavax (NVAX) Stock Up 20% Today?
Novavax continues to march higher in its recovery efforts, with its latest vaccine announcement lifting NVAX stock.
Why Is Fresh2 Group (FRES) Stock Up 31% Today?
Fresh2 Group stock is up on Tuesday with heavy pre-market trading of FRES shares despite a lack of news from the biotechnology company.
GSK Stock Falls as 70,000 Zantac Lawsuits Move Forward. What to Know.
Investors in GlaxoSmithKline are seeing a lot of red on their screens today, as GSK stock falls more than 8% on big legal news.
Structure Therapeutics (GPCR) Stock Soars 60% on Weight Loss Drug Success
GPCR stock shot up 60% today after Structure Therapeutics announced positive data from its mid-stage weight loss pill trials.
Why Is NovaBay Pharmaceuticals (NBY) Stock Down 39% Today?
NovaBay Pharmaceuticals stock is down on Thursday after the company announced a reverse split for shares of NBY happening today.
Why Is Cue Health (HLTH) Stock Up 99% Today?
Cue Health stock is up on Thursday with heavy trading of HLTH shares despite the company's recent bankruptcy filing.